Author

Patricia Liz Rae

Institution: Novartis (United States)

Observed institution: Novartis (United States)

OpenAlex ID: A5001928375

A Phase I/II Study of BHQ880, a Novel Osteoblat Activating, Anti-DKK1 Human Monoclonal Antibody, in Relapsed and Refractory Multiple Myeloma (MM) Patients Treated with Zoledronic Acid (Zol) and Anti-Myeloma Therapy (MM Tx).

2009 · Swaminathan Padmanabhan, Joseph Thaddeus Beck, et al. · Blood · 22

Works count: 1

Citation count: 22

H-index: 1

I10-index: 1